Qingdao Haier Biomedical Co Ltd
SSE:688139

Watchlist Manager
Qingdao Haier Biomedical Co Ltd Logo
Qingdao Haier Biomedical Co Ltd
SSE:688139
Watchlist
Price: 35.69 CNY -2.96% Market Closed
Market Cap: 11.3B CNY
Have any thoughts about
Qingdao Haier Biomedical Co Ltd?
Write Note

Qingdao Haier Biomedical Co Ltd
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Qingdao Haier Biomedical Co Ltd
Other Operating Expenses Peer Comparison

Comparables:
A
688617
J
002223
300760
J
300529
688271

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Qingdao Haier Biomedical Co Ltd
SSE:688139
Other Operating Expenses
ÂĄ51.1m
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Other Operating Expenses
ÂĄ54.8m
CAGR 3-Years
55%
CAGR 5-Years
47%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Other Operating Expenses
ÂĄ169.1m
CAGR 3-Years
38%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Other Operating Expenses
ÂĄ351.3m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Other Operating Expenses
ÂĄ38.6m
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Other Operating Expenses
ÂĄ582.2m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Qingdao Haier Biomedical Co Ltd's Other Operating Expenses?
Other Operating Expenses
51.1m CNY

Based on the financial report for Dec 31, 2023, Qingdao Haier Biomedical Co Ltd's Other Operating Expenses amounts to 51.1m CNY.

What is Qingdao Haier Biomedical Co Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
5%

Over the last year, the Other Operating Expenses growth was 18%. The average annual Other Operating Expenses growth rates for Qingdao Haier Biomedical Co Ltd have been 6% over the past three years , 5% over the past five years .

Back to Top